| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.051 | 0.3 |